¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"muscle receptor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
¿µ¹® muscle biopsy ÇÑ±Û ±ÙÀ°»ý°Ë
¼³¸í   
  »ýü³»¿¡¼­ ±ÙÀ°¿¡ ´ëÇÑ Áúº´ÀÇ °¨º°Áø´ÜÀ» À§Çؼ­ ½Ç½ÃÇϴ °Ë»ç¹ý. ¹æ¹ýÀº º´ÅͰ¡ Àִ ºÎÀ§³ª È¤Àº ¾ø¾îµµ Å©°Ô È°µ¿¿¡ ÁöÀåÀÌ ¾ø´Â ±ÙÀ°ºÎÀ§ÀÇ Á¶Á÷À» ¶¼¾î Çö¹Ì°æÀûÀ¸·Î °Ë»çÇÑ´Ù. ¿¹¸¦ µé¾î ½Å°æÁ¶Á÷ÀÇ ÀÌ»óÀ¸·Î ÀÎÇÑ ±ÙÀ°º´ÅÍÀÇ °æ¿ì, ±ÙÀ°»ý°ËÀ» ÇÏ¿© °üÂûÇØº¸¸é À̸¥¹Ù ¡°¹«¸®Áø À§Ãà(grouped atrophy)¡±ÀÌ ³ªÅ¸³ª¼­, ´Ù¸¥ º´ÅÍ¿¡ ÀÇÇÑ °Í°ú °¨º°ÀÌ °¡´ÉÇÏ´Ù.
¿µ¹® smooth muscle ÇÑ±Û ¹Î¹«´Ì±ÙÀ°, ÆòȰ±ÙÀ°
¼³¸í   
  ±ÙÀ° Áß¿¡¼­ °¡·Î¹«´Ì°¡ ¾ø´Â ±Ù. °¡·Î¹«´Ì±Ù¿¡ ´ëÀÀµÇ´Â ¸»ÀÌ´Ù. Ã´Ãßµ¿¹°¿¡¼­´Â ½ÉÀå±Ù ÀÌ¿ÜÀÇ ³»Àå±ÙÀº ¸ðµÎ°¡ ¹Î¹«´Ì±ÙÀÌ´Ù. ¸¹Àº ³»ÀåÀå±âÀÇ º®¿¡ ºÐÆ÷µÇ¾î ÀÖÀ¸¸ç, ´ë°³ µ¹¸²Ãþ°ú ¼¼·ÎÃþÀÇ µÎ ÃþÀ¸·Î ¹è¿­µÇ¾î ÀÖ´Ù. ¼ÒÈ­°üÀ̳ª ¿ä°ü °°Àº °ü¸ð¾çÀÇ ±¸Á¶¿¡¼­´Â ²ÞƲ¿îµ¿À» ÀÏÀ¸ÄÑ ³»¿ë¹°ÀÌ ¾Æ·¡·Î ³»·Á°¡°Ô Çϴ ÀÛ¿ëÀ» ÇÑ´Ù. Ç×¹®°ü, À§, ¿äµµ µî¿¡¼­´Â µ¹¸²ÃþÀÇ ±ÙÀ°À̠ƯÈ÷ µÎ²¨¿öÁ® ³»¿ë¹°ÀÌ ³»·Á°¡´Â °ÍÀ» Á¶ÀýÇϴ Á¶ÀÓ±ÙÀ°ÀÌ Çü¼ºµÇ¾î ÀÖ´Ù. Ç÷°ü¿¡´Â µ¹¸²Ãþ¸¸ ÀÖÀ¸¸ç, Ç÷°üÀ» ¼öÃàÇÏ¿© Ç÷¾×À» Áã¾îÂ¥´Â ÀÛ¿ëÀ» ÇÑ´Ù. ¶ÇÇÑ ÀÚÀ²½Å°æÀÇ Áö¹è¸¦ ¹ÞÀ¸¸ç, ¿ì¸®ÀÇ ÀÇÁö¿Í °ü°è¾øÀÌ ÀÛ¿ëÇÑ´Ù.
¿µ¹® voluntary muscle ÇÑ±Û ¼öÀDZÙ
¼³¸í   
  ÀÇÁöÀÇ ÈûÀ¸·Î ¿òÁ÷ÀÏ ¼ö Àִ ±ÙÀ°. °ñ°Ý±Ù ¿Ü¿¡ ÇǺΠ³»ÀÇ ÇDZÙ, °üÀýÁÖ¸Ó´Ï¿¡ ºÎÂøÇϰí Àִ °üÀý±Ù µîÀÌ ¿©±â¿¡ ¼ÓÇÑ´Ù. ¼öÀDZÙÀÇ ±Ù¼¶À¯¿¡´Â °¡·Î¹«´Ì°¡ ÀÖÀ¸¹Ç·Î °¡·Î¹«´Ì±ÙÀ̶ó°íµµ Çϳª, ½ÉÀå±ÙÀº °¡·Î ¹«´Ì°¡ À־ ¼öÀDZÙÀÌ ¾Æ´Ï¹Ç·Î ¼öÀDZٰú °¡·Î¹«´Ì±ÙÀº µ¿ÀǾî´Â ¾Æ´Ï´Ù. ¼öÀDZÙÀÇ ¿îµ¿Àº ¹Î¹«´Ì±Ùº¸´Ù ºü¸£´Ù. ¼öÀDZÙÀ̶ó Çصµ °ñ°Ý±Ù µîÀº ±ÙÀ°¹«¸®·Î¼­ ¿òÁ÷ÀÏ ¼ö ÀÖÀ¸³ª, °³°³ÀÇ ±ÙÀ°Àº µû·Îµû·Î ¸¶À½´ë·Î ¿òÁ÷À̰ԠÇÒ ¼ö ¾ø´Ù. ±Ó¹ÙÄû±ÙÀ°Àº »ç¶÷ÀÇ °æ¿ì ¹ßÀ°ÀÌ ³ªºü ¸¶À½´ë·Î ¿òÁ÷À̰ԠÇÏ±â ¾î·Æ´Ù. 
¿µ¹® facial muscle ÇÑ±Û ¾ó±¼±ÙÀ°
¼³¸í   
  ¾ó±¼ÀÇ ÇǺθ¦ ¿òÁ÷À̰í ÀÌ¿¡ ºÎÂøµÇ¾î Àִ ¾ó±¼½Å°æÀÇ °ø±ÞÀ» ¹Þ´Â ¼ö¸¹Àº ±ÙÀ°À» Æ÷ÇÔÇϴ ¾ó±¼Ç¥Á¤±ÙÀ̳ª ¸ð¹æ±Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gustatory receptor
    ¹Ì°¢¼ö¿ë±â
  • H1 receptor
    H1¼ö¿ëü
  • H2 receptor
    H2¼ö¿ëü
  • heat receptor
    ¿­¼ö¿ë±â
  • hairy skin receptor
    ÅÐÇǺμö¿ë±â
  • histamine receptor
    È÷½ºÅ¸¹Î¼ö¿ëü
  • homing receptor
    ±Í¼Ò¼ö¿ëü
  • immunoglobulin adhesion receptor
    ¸é¿ª±Û·ÎºÒ¸°ºÎÂø¼ö¿ëü
  • insulin receptor
    Àν¶¸°¼ö¿ëü
  • insulin receptor substrate-1
    Àν¶¸°¼ö¿ëü±âÁú-1
  • interferon receptor
    ÀÎÅÍÆä·Ð¼ö¿ëü
  • internalization receptor
    ³»ÀçÈ­¼ö¿ëü
  • joint receptor
    °üÀý¼ö¿ë±â
  • kinesthetic receptor
    ¿îµ¿°¨°¢¼ö¿ë±â
  • labyrinthine receptor
    ¹Ì·Î¼ö¿ë±â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gastrocnemius muscle
    ÀåµýÁö±Ù
  • gluteus muscle
    º¼±â±Ù, µÐ±Ù
  • hamstring muscle
    µÚ³Ò´Ù¸®±Ù
  • iliopsoas muscle
    ¾ûµ¢Ç㸮±Ù
  • involuntary muscle
    ºÒ¼öÀDZÙ, Á¦´ë·Î±Ù
  • levator ani muscle
    Ç×¹®¿Ã¸²±Ù
  • orbicularis oculi muscle
    ´«µÑ·¹±Ù
  • pectoralis major muscle
    Å«°¡½¿±Ù, ´ëÈä±Ù
  • pterygoid muscle
    ³¯°³±Ù
  • quadriceps femoris muscle
    ³Ò´Ù¸®³×°¥·¡±Ù, ´ëÅð»çµÎ±Ù
  • rectus femoris muscle
    ³Ò´Ù¸®°ðÀº±Ù
  • red muscle
    Àû»ö±ÙÀ°
  • skeletal muscle
    °ñ°Ý±Ù
  • smooth muscle
    ¹Î¹«´Ì±Ù, ÆòȰ±Ù
  • soleus muscle
    °¡Àڹ̱Ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dominant receptor
    ¿ì¼º¼ö¿ëü
  • early receptor potential
    Á¶±â½Ã°¢¼¼Æ÷ÀüÀ§
  • electromagnetic receptor
    ÀüÀÚ±â¼ö¿ëü
  • receptor destroying enzyme
    ¼ö¿ëüÆÄ±«È¿¼Ò
  • free receptor
    À¯¸®¼ö¿ëü
  • gustatory receptor
    ¹Ì°¢¼ö¿ëü
  • receptor gradient
    ¼ö¿ë´Ü¹é±â¿ï±â, ¼ö¿ë´Ü¹é°æ»ç
  • hairy skin receptor
    ÅÐÇǺμö¿ëü
  • heat receptor
    ¿­¼ö¿ëü
  • histamine receptor
    È÷½ºÅ¸¹Î¼ö¿ëü
  • homing receptor
    ±Í¼Ò¼ö¿ëü
  • receptor hypothesis
    ¼ö¿ëü°¡¼³
  • immunoglobulin adhesion receptor
    ¸é¿ª±Û·ÎºÒ¸°ºÎÂø¼ö¿ëü
  • insulin receptor
    Àν¶¸°¼ö¿ëü
  • interferon receptor
    ÀÎÅÍÆä·Ð¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • CR2 => complement receptor 2
    º¸Ã¼¼ö¿ëü 2
  • CR3 => complement receptor 3
    º¸Ã¼¼ö¿ëü 3
  • CR4 => complement receptor 4
    º¸Ã¼¼ö¿ëü 4
  • Gustatory receptor
    ¹Ì°¢¼ö¿ëü(Ú«ÊÆâ¥é»ô÷)
  • H2 receptor antagonist
    H2 ¼ö¿ëü ±æÇ×Á¦µé
  • Ig receptor
    ¸é¿ª±Û·ÎºÒ¸° ¼ö¿ëü
  • Internalization, receptor
    ³»È­(Ò®ü§), ¼ö¿ëü(áôé»ô÷)
  • Kainate amino acid receptor
    Ä«À̳×ÀÌÆ® ¾Æ¹Ì³ë»ê ¼ö¿ëü(áôé»ô÷)
  • Kinesthetic receptor
    ¿îµ¿(ê¡ÔÑ)(°¨(Êï))°¢¼ö¿ëü(ÊÆáôé»ô÷)
  • NMDA receptor
    ¿£¾Úµð¿¡ÀÌ ¼ö¿ëü
  • T cell receptor
    T¼¼Æ÷[Ç׿ø]¼ö¿ëü
  • T cell receptor gene
    T¼¼Æ÷[Ç׿ø]¼ö¿ëü À¯ÀüÀÚ
  • acetylcholine receptor
    ¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
  • acetylcholine receptor
    ¾Æ¼¼Æ¿Äݸ°¼ö¿ëü
  • acetylcholine receptor antibody
    ¾Æ¼¼Æ¿Äݸ°¼ö¿ëüÇ×ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • latissimus dorsi muscle ; muscle latissimus dorsi
    ±¤¹è±Ù.
  • least abductor muscle of little toe<³ª> muscle abductor digiti minimi
    ¼ÒÁö ¿ÜÀü±Ù.
  • least abductor muscle of little toe<³ª> muscle abductor digiti minimi
    ¼ÒÁö¿ÜÀü±Ù.
  • lesser psoas muscle ; muscle psoas minor
    ¼Ò ¿ä ±Ù(á³é¦ÐÉ).
  • lesser psoas muscle ; muscle psoas minor
    ¼Ò¿ä±Ù.
  • levator muscle of upper lip ; muscle levator labii superioris
    »ó¼ø°Å±Ù<¾È¿ÍÇϱÙ>.
  • levator muscle of upper lip =muscle levator labii
    »ó¼ø°Å±Ù
  • lip, levator muscle of upper =muscle levator labi
    »ó¼ø°Å±Ù
  • long extensor muscle of great toe ³ª muscle extensor hallucis longus
    Àå ¹«Áö ½Å±Ù.
  • long extensor muscle of thumb ³ª muscle extensor pollicis longus
    Àå ¸ðÁö ½Å±Ù.
  • long extensor muscle of toes ³ª muscle extensor digitorum longus
    Àå Áö ½Å±Ù.
  • long flexor muscle of great toe ³ª muscle flexor hallucis longus
    Àå ¹«Áö±¼±Ù.
  • long flexor muscle of thumb ³ª muscle flexor pollicis longus
    Àå ¸ðÁö ±¼±Ù.
  • long flexor muscle of toes ³ª muscle flexor digitorum longus
    Àå Áö±¼ ±Ù.
  • long head of biceps muscle of arm ³ª caput longum muscle bicipitis brachii
    »ó¿Ï À̵α٠Àå µÎ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Transversus auricularis muscle
    ±Ó¹ÙÄû°¡·Î±Ù
    [¿¾ ¿ë¾î] À̰³È¾±Ù
  • Obliquus auricularis muscle
    ±Ó¹ÙÄûºø±Ù
    [¿¾ ¿ë¾î] À̰³»ç±Ù
  • Auricular pyramidal muscle
    ±Ó¹ÙÄûÇǶó¹Ô±Ù
    [¿¾ ¿ë¾î] À̰³Ãßü±Ù
  • Muscle fascicle
    ±ÙÀ°´Ù¹ß
    [¿¾ ¿ë¾î] ±Ù¼Ó
  • Muscle fiber
    ±ÙÀ°¼¶À¯
    [¿¾ ¿ë¾î] ±Ù¼¶À¯
  • Satellite cell of skeletal muscle
    ±ÙÀ°À§¼º¼¼Æ÷
    [¿¾ ¿ë¾î] ±ÙÀ§¼º¼¼Æ÷
  • Muscle layer
    ±ÙÀ°Ãþ
    [¿¾ ¿ë¾î] ±ÙÃþ
  • Tracheal muscle
    ±â°ü±Ù
    [¿¾ ¿ë¾î] ±â°ü±Ù
  • Bronchial muscle
    ±â°üÁö±Ù
    [¿¾ ¿ë¾î] ±â°üÁö±Ù
  • Bronchoesophageal muscle
    ±â°üÁö½Äµµ±Ù
    [¿¾ ¿ë¾î] ±â°üÁö½Äµµ±Ù
  • Sulcus for flexor hallucis longus muscle
    ±ä¾öÁö±ÁÈû±ÙÈûÁÙ°í¶û
    [¿¾ ¿ë¾î] Àå¸ðÁö±¼±Ù°Ç±¸
  • Sulcus for peroneus longus muscle
    ±äÁ¾¾Æ¸®±ÙÈûÁÙ°í¶û
    [¿¾ ¿ë¾î] Àåºñ°ñ±Ù°Ç±¸
  • Bipennate muscle
    ±ê±ÙÀ°
    [¿¾ ¿ë¾î] ¿ì»ó±Ù
  • Deep transverse perineal muscle
    ±íÀº»ô°¡·Î±Ù
    [¿¾ ¿ë¾î] ½ÉȸÀ½È¾±Ù
  • Coccygeus muscle
    ²¿¸®±Ù
    [¿¾ ¿ë¾î] ¹Ì°ñ±Ù
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • glucocorticoid receptor
    ±Û·çÄÚÄÚ¸£Æ¼ÄÚÀÌµå ¼ö¿ëü(áôé»ô÷)
  • H1 receptor
    H1 ¼ö¿ëü(áôé»ô÷)
  • H2 receptor
    H2 ¼ö¿ëü(áôé»ô÷)
  • LDL receptor
    LDL ¼ö¿ëü(áôé»ô÷)
  • ligand-receptor internalization
    ¸®°£µå-¼ö¿ëü(áôé»ô÷) ³»ÀÔ(Ò®ìý)
  • mineralocorticoid receptor
    ±¤Áú(ÎÎòõ) ÄÚ¸£Æ¼ÄÚÀÌµå ¼ö¿ëü(áôé»ô÷)
  • mobile receptor model
    À̵¿¼ö¿ëü(ì¹ÔÑáôé»ô÷) ¸ðµ¨
  • muscarinic receptor
    ¹«½ºÄ«¸°¼ö¿ëü(áôéÄô÷)
  • nicotinic receptor
    ´ÏÄÚÆ¾¼ö¿ëü(â¥é»ô÷)
  • opiate receptor
    ¾ÆÆíÁ¦(ð¥) ¼ö¿ëü(áôé»ô÷)
  • opioid receptor
    ¾ÆÆí°è(ͧ) ¾à¹°¼ö¿ëü(å·Úªáôé»ô÷)
  • receptor
    ¼ö¿ëü(áôé»ô÷)
  • receptor destroying enzyme
    ¼ö¿ëü ÆÄ±«È¿¼Ò(áôé»ô÷÷òÎÕý£áÈ)
  • receptor down regulation
    ¼ö¿ëü ÇÏÇâ Á¶Àý(áôé»ô÷ù»ú¾ðàï½)
  • receptor element
    ¼ö¿ëü Á¶Àý ¿ä¼Ò(áôé»ô÷ðàï½é©áÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inferior rectus muscle
    ÇÏÁ÷±Ù
  • intercostal muscle
    ´Á°£±Ù
  • internal obturator muscle
    ³»Æó¼â±Ù
  • laryngeal muscle
    ÈĵαÙ
  • lateral pterygoid muscle
    ¿ÜÃøÀ͵¹±Ù
  • lateral rectus muscle
    ¿ÜÁ÷±Ù
  • levator muscle
    °Å±Ù
  • levator veli palatini muscle
    ±¸°³°Å±Ù
  • long head of biceps muscle of thigh
    ´ëÅðÀ̵αÙÀåµÎ
  • longus capitis muscle
    µÎÀå±Ù
  • masticatory muscle
    ÀúÀÛ±Ù, ±³±Ù
  • medial rectus muscle
    ³»Ãø°ðÀº±Ù, ³»Á÷±Ù
  • muscle
    ±ÙÀ°
  • muscle atrophy
    ±ÙÀ§Ãà
  • muscle bundle
    ±Ù´Ù¹ß, ±Ù¼Ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LM lactic acid mineral [medium]; lactose malabsorption; laryngeal mask; laryngeal muscle; lateral malle...
MG Marcus Gunn [pupil]; margin; medial gastrocnemius [muscle]; membranous glomerulonephritis; menopausa...
MS Maffuci syndrome; maladjustment score; mandibular series; Marfan syndrome; Marie-Strumpell [syndrome...
PM after death (Lat. post mortem); after noon [Lat. post meridiem]; mean pressure; pacemaker; pantomogr...
MRO master reference oscillator; medical review officer; minimal recognizable odor; muscle receptor orga...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ADM Abductor digiti minimi muscle
ASM Airway smooth muscle
alpha-SMA Alpha smooth muscle actin
ASMA Alpha-smooth muscle actin
ASMC aortic smooth muscle cell
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • free receptor
    À¯¸® ¼ö¿ëü
  • image receptor
    »ó ¼ö¿ë±â
  • k receptor
    k ¼ö¿ë±â
  • kapa receptor
    Ä«ÆÄ ¼ö¿ëü
  • ligand receptor binding
    ¸®°£µå ¼ö¿ë±â °áÇÕ
  • multiple somatic receptor
    ´Ù¹ß¼º ü ¼ö¿ëü, ´Ù¹ß¼º ü ¼ö¿ë±â
  • opiate analgesia receptor
    ¾ÆÆí¼º ÁøÅë ¼ö¿ëü, ¾ÆÆí¼º ÁøÅë ¼ö¿ë±â
  • opiate receptor
    ¾ÆÆí ¼ö¿ëü, ¾ÆÆí ¼ö¿ë±â
    1. ¥ì : ¥ì1Àº µ¿Åë Á¶Àý ¾àÁ¦°¡ °áÇÕ, ¥ì2¿Í °áÇսô ȣÈíÀÌ ¾ïÁ¦µÈ´Ù. 2. ¥ê¿Í °áÇÕ ½Ã Â÷ºÐÇØÁø´Ù. 3. ¥ä : ¸ö¿¡¼­ »ý¼ºµÇ´Â ³»Àμº o
  • peripheral receptor
    ¸»ÃÊ ¼ö¿ëü, ¸»ÃÊ ¼ö¿ë±â
  • pressure receptor
    ¾Ð¼ö¿ë±â, ¾Ð·Â¼ö¿ëü
    µ¿ÀǾî=
  • receptor
    ¼ö¿ë±â, ¼ö¿ëü, °¨¼öü
    1. ¼¼Æ÷Áú ³» ¶Ç´Â ¼¼Æ÷ Ç¥¸é¿¡ Á¸ÀçÇÏ´Â ºÐÀÚ ±¸Á¶·Î¼­
  • receptor activation
    ¼ö¿ëü Ȱ¼ºÈ­, ¼ö¿ë±â Ȱ¼ºÈ­
  • receptor blocking agent
    ¼ö¿ëü Â÷´ÜÁ¦
  • receptor complex
    ¼ö¿ëü º¹ÇÕü, ¼ö¿ë±â º¹ÇÕü
  • receptor destroying enzyme
    ¼ö¿ëü ÆÄ±« È¿¼Ò
    ¼ö¿ëü¸¦ ÆÄ±«ÇÏ¿© ÀûÇ÷±¸ÀÇ ¹ÙÀÌ·¯½º ¿ëÇ÷¿¡ ´ëÇÑ °¨¼ö¼ºÀ» ÀÒ¾î¹ö¸®°Ô ÇÏ´Â È¿¼Ò.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
gene rearrangement, delta-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the delta-chain of antigen receptors.
(12 Dec 1998)
gene rearrangement, gamma-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the gamma-chain of antigen receptors.
(12 Dec 1998)
genes, T-cell receptor DNA sequences, in cells of the t-lymphocyte lineage, that code for T-cell receptors. The tcr genes are formed by somatic rearrangement (see gene rearrangement, t-lymphocyte and its children) of germline gene segments, and resemble ig genes in their mechanisms of diversity generation and expression.
(12 Dec 1998)
genes, T-cell receptor alpha DNA sequences encoding the alpha chain of the T-cell receptor. The genomic organization of the tcr alpha genes is essentially the same in all species and is similar to the organization of ig genes.
(12 Dec 1998)
genes, T-cell receptor beta DNA sequences encoding the beta chain of the T-cell receptor. The genomic organization of the tcr beta genes is essentially the same in all species and is similar to the organization of ig genes.
(12 Dec 1998)
genes, T-cell receptor delta DNA sequences encoding the delta chain of the T-cell receptor. The delta-chain locus is located entirely within the alpha-chain locus.
(12 Dec 1998)
genes, T-cell receptor gamma DNA sequences encoding the gamma chain of the T-cell receptor. The human gamma-chain locus is organised similarly to the tcr beta-chain locus.
(12 Dec 1998)
receptor 1. A molecular structure within a cell or on the surface characterised by selective binding of a specific substance and a specific physiologic effect that accompanies the binding, for example, cell surface receptors for peptide hormones, neurotransmitters, antigens, complement fragments and immunoglobulins and cytoplasmic receptors for steroid hormones.
2. A sensory nerve terminal that responds to stimuli of various kinds.
(18 Nov 1997)
receptor aggregation Chemically stimulated aggregation of cell surface receptors, which potentiates the action of the effector cell.
(12 Dec 1998)
receptor agonist A substance that mimics a specificneurotransmitter, is able to attach to that neurotransmitter's receptor and thereby produces the same action that theneurotransmitter usually produces. Drugs are often designed as receptor agonists to treat a variety of diseases and disorders whenthe original chemical substance is missing or depleted.
(22 May 1997)
receptor-CD3 complex, antigen, T-cell Molecule composed of the non-covalent association of the T-cell antigen receptor (receptors, antigen, T-cell) with the CD3 complex (antigens, CD3). This association is required for the surface expression and function of both components. The molecule consists of up to seven chains: either the alpha/beta or gamma/delta chains of the T-cell receptor, and four or five chains in the CD3 complex.
(12 Dec 1998)
receptor, chemokine A molecule that receives a chemokine and acts as a dock for a chemokine. Several chemokine receptors are essential co-receptors for HIV.
(12 Dec 1998)
receptor downregulation A phenomenon observed in many cells: following stimulation with a ligand the number of receptors for that ligand on the cell surface diminishes because internalisation exceeds replenishment. Often used very loosely, thus destroying the utility of the term.
(18 Nov 1997)
receptor mediated endocytosis Endocytosis of molecules by means of a specific receptor protein that normally resides in a coated pit, but may enter this structure after complex formation occurs. The structure then forms a coated vesicle that delivers its contents to the endosome whence it may enter the cytoplasm or the lysosomal compartment. Many bacterial toxins and viruses enter cells by this route.
(18 Nov 1997)
receptor potential The transmembrane potential difference of a sensory cell. Such cells are not generally excitable, but their response to stimulation is a gradual change in their resting potential.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á